Your browser doesn't support javascript.
loading
Boosting of Waned Humoral and Cellular Responses to SARS-CoV-2 Variants of Concern Among Patients with Cancer.
McKenzie, Duncan R; Graham, Rosalind; Lechmere, Thomas; Domingo-Vila, Clara; Alaguthurai, Thanussuyah; Arman, Celeste; Pollock, Emily; Gousis, Charalampos; Kakkassery, Helen; Carpenter, Esme; Kurshan, Ashwini; Vidler, Jennifer; Kulasekararaj, Austin; Patten, Piers; North, Bernard V; Tree, Timothy; Doores, Katie J; Hayday, Adrian C; Irshad, Sheeba.
  • McKenzie DR; The Francis Crick Institute, London, United Kingdom.
  • Graham R; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Lechmere T; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.
  • Domingo-Vila C; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
  • Alaguthurai T; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Arman C; Breast Cancer Now Research Unit, King's College London, London, United Kingdom.
  • Pollock E; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Gousis C; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
  • Kakkassery H; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Carpenter E; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Kurshan A; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Vidler J; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.
  • Kulasekararaj A; Department of Haematological Medicine, King's College Hospital, London, United Kingdom.
  • Patten P; Department of Haematological Medicine, King's College Hospital, London, United Kingdom.
  • North BV; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
  • Tree T; Department of Haematological Medicine, King's College Hospital, London, United Kingdom.
  • Doores KJ; Clinical Trials Unit, King's College London, London, United Kingdom.
  • Hayday AC; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
  • Irshad S; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.
Cancer Res Commun ; 2(11): 1449-1461, 2022 11 17.
Article en En | MEDLINE | ID: mdl-36824220
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / COVID-19 / Neoplasias Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Hematológicas / COVID-19 / Neoplasias Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article